UCL Cancer Institute


Welcome to the UCL Cancer Institute 

The UCL Cancer Institute is the hub for cancer research at University College London, one of the World's leading universities. The Institute draws together over 300 talented scientists who are working together to translate research discoveries into developing better, more effective treatments to improve outcomes for cancer patients. If you are considering postgraduate study with us, applications to our flagship MSc Cancer programme are open and our Constance Travis studentship is available for research students. 


Cancer Research UK-UCL Centre receives £4m Accelerator Award

Cancer Research UK is investing £16m in four UK-wide collaborations to inspire new approaches to understanding and treating cancers with low survival.  The Cancer Research UK-UCL Centre will receive £4 million to roll out a national post-mortem tissue bank from patients with hard to treat and metastatic cancer. The study, led by Professor Charles Swanton, will be vital for understanding the evolution and final stages of the disease and researching the genetics of brain tumours.

Published: May 20, 2016 11:43:27 AM

Epigenetics discovery provides new insight into cellular memory

Researchers have identified a new cellular mechanism involving a protein complex that helps control the identity of cells and dictates which genes are turned off. The findings, published in Genome Research, could potentially inform future stem cell therapies through cell reprogramming and provide vital clues about specific processes that are adversely modified in cancer cells. 

Published: May 20, 2016 11:43:27 AM

New team to develop radiotherapies that target cancer more effectively

Safer precision radiotherapies that will be able to cure more cancers with fewer side-effects will be available within five years under ambitious new plans for research and treatment at the UCL Cancer Institute and University College London Hospitals (UCLH) NHS Foundation Trust. UCL and UCLH have appointed Professor Ricky Sharma, a world-leading oncologist from Oxford University specialising in radiotherapy and cancer biology, to lead the new clinical research programme alongside a team of top physicists.

Published: Apr 21, 2016 10:37:41 PM

Gene editing activates cancer-killing immune cells

In a new study published today in Cancer Research, a UCL research team led by Professor Karl Peggs and Dr Sergio Quezada have discovered that cutting off a sleep-switch on immune cells inside a tumour wakes up the cells and enables the immune system to hunt down and destroy cancer. 

Published: Apr 15, 2016 1:22:05 PM

Cancer Research UK-UCL Centre

Cancer Research UK-UCL Centre

The Cancer Research UK-UCL Centre is a network and partnership between Cancer Research UK, UCL and UCL's associated Hospital Trusts. The Centre's mission is to facilitate collaboration to advance world-class translational cancer research.

Study with us

Study with us

Our education programmes reflect the depth and breadth of research expertise within the UCL Cancer Institute. Join our community of research scientists and academic clinicians through our postgraduate taught MSc Cancer or PhD studies.

Clinical Trials

Clinical Trials

The Cancer Research UK and UCL Cancer Trials Centre is one of the largest cancer trials centres in the UK. The CTC conducts multi-centre national and international phase III trials, feasibility studies and early phase I and II studies.

Our Research

Our Research

UCL is a world leader in interdisciplinary research. The UCL Cancer Institute us uniquely placed to leverage this multidisciplinary approach to advance discoveries in basic, translational and clinical cancer research.


No articles are available.

Support our work

The progress we make in understanding and developing treatments for cancer is made possible by the generous support of individuals, companies and charitable trusts and foundations. Our donors support us every step of the way in the ongoing fight against cancer. 

Find out more about how you can help us to continue research that will lead to breakthroughs in cancer therapies and benefit the lives of cancer patients.


Taking action for equality

Athena Swan silver logo

Connect with us